NCT00307580View on ClinicalTrials.gov

Cathflo Activase Pediatric Study

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

May 31, 2003

Conditions
Dysfunctional Central Venous Access Devices (CVADS)
Interventions
DRUG

Cathflo Activase (Alteplase)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00307580 - Cathflo Activase Pediatric Study | Biotech Hunter | Biotech Hunter